Only losing 1 pound a week on Mounjaro — is that normal?

The misconception: slow weeks mean Mounjaro isn't working

The most common worry people bring to this topic is the idea that a week of small losses proves the medicine has stopped working, or was never working. It's an understandable fear, and it deserves a gentle but direct answer: weekly weight loss is one of the noisiest signals in the whole process. Fluid shifts, the composition of your last meal, where you are in your menstrual cycle, how much sleep you've had, all of these move the scale by more than a pound without touching your fat mass at all.

Clinical trials don't measure week-by-week variation for this very reason. The SURMOUNT-1 trial, published in the New England Journal of Medicine, tracked average body-weight reduction over 72 weeks, a timescale that irons out the noise entirely. Over that period, participants on the highest doses lost around 20–21% of their body weight on average. That works out to roughly a pound per week across the whole trial. If only losing a pound a week on Mounjaro feels slow, it's worth knowing that's broadly consistent with trial-level averages, depending on your starting point and current dose.

The honest advice is this: look at your trend over four to six weeks, not at any single weigh-in. One flat week surrounded by consistent loss is not a plateau. It's Tuesday.

How your current dose shapes the number you're seeing

Mounjaro is started at 2.5mg, a dose whose job is to let your body adjust to the medicine, not to deliver maximum effect. It's the first rung of a six-step ladder that reaches 15mg, and for most people the bigger losses become more consistent as the dose increases over subsequent months. Expecting 15mg results at 2.5mg or 5mg is a common source of unnecessary frustration.

This matters practically. If you're a few weeks into treatment on a lower dose and losing around a pound a week, that rate may well increase as your prescriber titrates upward, provided you're tolerating the current dose well. The NHS patient information on tirzepatide outlines the standard titration schedule and what the different doses are for. Your prescriber reviews all of this before any change is made.

There's also an important point about muscle. When people reduce their calorie intake significantly, some of what the body loses is lean tissue as well as fat. Eating enough protein and staying active (particularly with strength-based movement) can help preserve muscle while fat comes off, which changes the composition of your loss even if it doesn't always change the speed. If you want to read more about the broader experience of losing weight on Mounjaro, including what different phases tend to look like, that page covers it in more depth.

When to take slow progress more seriously

There is a difference between normal weekly variation and a genuine, sustained stall. If you're on a stable maintenance dose, following a reduced-calorie diet and staying active, and you've lost less than 5% of your starting body weight after six months, that's a conversation worth having with your prescriber. NICE's guidance on tirzepatide (TA1026) notes that continuing treatment should be reviewed if meaningful weight loss hasn't occurred by that point. This isn't a failure; it reflects the fact that these medicines work better for some people than others, and clinical review exists precisely to assess that.

Other things worth raising with your prescriber or our aftercare team: if nausea or other gastrointestinal symptoms are making it genuinely difficult to eat enough, or if you're worried about hair changes (a recognised but usually temporary effect, this page on hair changes during treatment explains what's known), or if you have questions about whether another aspect of your health is affecting your response. These aren't reasons to stop; they're reasons to stay in contact.

Mounjaro is a prescription medicine, a clinician decides what's appropriate, and no guidance here substitutes for that conversation. Our prescribers are available seven days a week for exactly these questions.

What a realistic timeline tends to look like

People starting tirzepatide often notice the clearest appetite changes around weeks four to eight, as the medicine reaches a steady level and the dose begins to increase. Weight loss in the first month can be modest; the curve typically steepens over months two to six. Progress is rarely a straight line, most people describe bursts of loss followed by quieter weeks, then another burst.

The wider picture on Mounjaro as a treatment (including eligibility, how it compares to other options, and what the clinical evidence covers) is worth reading if you're still weighing up the process. And if the current cost of treatment is part of your thinking, this explanation of how Mounjaro's UK pricing has changed gives useful context without glossing over the numbers.

If you'd like a prescriber to review where you are in treatment, or you're considering starting, you're welcome to check your eligibility with us, consultations are free, and every one is reviewed by a GPhC-registered prescriber the same day.